Home
>
Stock Market
>
>
Kwality Pharmaceuticals Ltd

Kwality Pharmaceuticals Ltd share price and stock overview

Kwality Pharmaceuticals Ltd (NSE: KPL, BSE: 539997) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE552U01010 and a face value of Rs 10. As of 12 November 2026, it trades at Rs (3,948.70) with a market capitalisation of Rs 4135.49 crore. Figures are live and subject to change.

Kwality Pharmaceuticals Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

NSE BSE

3,948.70 -35.10 (-0.88%) downArrowC

As on: 12-Nov-2026 , 09:47 PM

Market Cap(₹Cr) 4135.49

Book Value(₹Cr) 320.5146991

BSE Code : 539997 NSE Symbol : KPL EPS(TTM) : 78.68 ISIN Demat : INE552U01010 P/E(TTM) : 50.66 Face Value(₹) : 10 Div & Yield % : 0

Today Market

Stock Performance

Today Market

Today's High

82,325.61

Todday's Low

81,576.15

Open at

81,762.27

Previous Close

81,879.40

Volumes

Avg Price

31.61

Historical Performance

News

12 Nov 26

Kwality Pharmaceuticals Ltd consolidated sales up 11.62% on year in Q2FY2027, net profit improved by 13.31%

Kwality Pharmaceuticals Ltd share price ticked higher by 3.34% to Rs 3985.55 after the company's net profit rose by 13.

28 Sep 26

Quality Pharmaceuticals closes trading window for insiders ahead of financial results

Quality Pharmaceuticals Limited informed the BSE Limited that the trading window for dealing in equity shares of the company will be closed for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ended September 30, 2026.

03 Sep 26

Kwality Pharmaceuticals members approved Kapoor and Arora for director roles through 2031

Kwality Pharmaceuticals Limited announced that its members approved the regularization of Swanith Kapoor as a Non-Executive Independent Director for a term of five consecutive years, effective June 2, 2026, to June 1, 2031, and the reappointment of Aditya Arora as Whole Time Director for a period of five years, effective September 30, 2026, to September 29, 2031.

10 Aug 26

Kwality Pharmaceuticals Ltd consolidated sales up 3.34% on year in Q2FY2026

Kwality Pharmaceuticals Ltd share price softened by 1.64% to Rs 2609.05. The Company's net profit inched up 1.

Historical Prices

Share Price Chart

Historical Share Price

Date	Open Price (₹)	High Price(₹)	Low Price(₹)	Close Price(₹)	Total Volume	No of Trades	Net Turnover(₹)	NIFTY
12-11-26	4050.00	4211.00	3708.40	3948.70	326979	58533	1322449411.60	25299.35
11-11-26	3899.90	4066.20	3780.50	3983.80	101620	17109	403323078.90	25255.05
09-11-26	3700.00	3887.20	3581.00	3856.40	73118	13776	276304024.20	25044.65
08-11-26	3699.00	3749.90	3642.70	3686.00	8482	1609	31400806.90	24986.40
06-11-26	3699.50	3724.20	3553.10	3644.80	20631	4748	74518408.00	25030.35
05-11-26	3820.00	3820.00	3670.00	3687.30	19739	4102	73791033.00	24536.60
04-11-26	3679.00	3783.00	3583.10	3741.00	36031	5175	134016335.60	23960.60
03-11-26	3515.00	3669.90	3506.30	3630.90	17826	4170	64493744.20	23810.85
02-11-26	3450.00	3566.30	3401.00	3515.90	14597	3262	51155364.00	23440.80
30-10-26	3699.00	3729.00	3457.10	3475.30	26862	6078	95480003.30	23053.10

12 3 ...

Fundamentals

Company Valuation

Market Cap (₹cr)

4135.49

PE Ratio

50.66

PB Ratio

12.43

Dividend Yield

ROE

22.54

ROCE

23.69

Book Value (₹)

320.5146991

Face Value (₹)

Share Holding Pattern

Category of Shareholder	No of Shares	% Share Holdings	Demat Shares	Share Holders

Promoter & Group

Foreign

Foreign (Promoter & Group) - Bodies Corporate	0	0.00	0	0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign)	0	0.00	0	0
Foreign Promoter(Institutional)	0	0.00	0	0
Promoter Others	0	0.00	0	0

Sub Total

0.00

Indian

Bodies Corporate-Indian (Promoter & Group)	0	0.00	0	0
Government(Central / State)-Indian (Promoter & Group)	0	0.00	0	0
Directors & their Relatives-Indian (Promoter & Group)	1580677	15.23	1580677	6
Financial Institutions / Banks-Indian (Promoter & Group)	0	0.00	0	0
Individuals / Hindu Undivided Family-Indian (Promoter & Group)	4112211	39.63	4112211	2
Partnership Firms-Indian (Promoter & Group)	0	0.00	0	0
Persons Acting in Concert	0	0.00	0	0
Trusts	0	0.00	0	0
Others	0	0.00	0	0

Sub Total

5692888

54.86

5692888

Total ShareHolding for Promoter & Group

5692888

54.86

5692888

Publice Share Holding

Institution

Government(Central / State)	0	0.00	0	0
Clearing Members	0	0.00	0	0
Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
Financial Institutions / Banks	0	0.00	0	0
Foreign Bank	0	0.00	0	0
Foreign Bodies Corporate/OCBs/FBC	0	0.00	0	0
Foreign Collaborators	0	0.00	0	0
Foreign Institutional Investors	259163	2.50	259163	7
Foreign Venture Capital Investors	0	0.00	0	0
Foreign Institution Other	0	0.00	0	0
Insurance Companies	0	0.00	0	0
Mutual Funds / UTI	187	0.00	187	2
Individuals (Non-Resident / Foreign)	0	0.00	0	0
NSDL Intransit	0	0.00	0	0
Others	110773	1.07	110773	7
Trusts	0	0.00	0	0
Venture Capital Funds	0	0.00	0	0

Sub total

370123

3.57

370123

Non Institution

Bodies Corporate	133887	1.29	133887	119
Clearing Members	1639	0.02	1639	6
Directors & their Relatives	0	0.00	0	0
Employees	0	0.00	0	0
Escrow Account	0	0.00	0	0
Foreign Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
NRIs/Foreign Individuals/Foreign Nationals	768199	7.40	768199	434
Foreign Non Institution Other	0	0.00	0	0
Hindu Undivided Families	65496	0.63	65496	381
Indian Public	0	0.00	0	0
Individuals holding nominal share capital in excess of Rs. 1 lakh	1609366	15.51	1567970	12
Individuals holding nominal share capital up to Rs. 1 lakh	1633860	15.75	1633860	16899
Market Maker	0	0.00	0	0
NSDL Transit	0	0.00	0	0
Shares in transit	0	0.00	0	0
Societies	0	0.00	0	0
Trust & Foundation	0	0.00	0	0
Others	100540	0.97	100540	1

Sub Total

4313187

41.57

4271791

17856

Total Public Shareholding

4683310

45.14

4641914

17872

Total of Promoter & Public ShareHolding

10376198

100.00

10334802

17880

Shares held by Custodians and against which Depository Receipts have been issued

ADR	0	0.00	0	0
GDR	0	0.00	0	0
Other Custodians	0	0.00	0	0

Total Shares held by Custodians and against which Depository Receipts have been issued

0.00

Grand Total

10376198

100.00

10334802

17880

Financials (₹ in cr)

Consolidated Standalone

Year End	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Net Sales	503.08	370.20	307.17	251.03	456.19
OPM (%)	17.95	14.62	12.44	16.77	35.42
OP	90.32	54.14	38.20	42.10	161.57
Other Income	2.86	1.92	1.83	2.94	3.51
PBIDT	120.27	82.31	61.04	46.55	175.17
INTEREST	10.97	9.88	10.39	6.02	2.92
PBDT	109.30	72.43	50.66	40.53	172.26
PBT	88.66	54.14	24.00	9.04	161.57
EO	-0.83	0.00	-7.10	-16.53	0.00
PBT after EO	89.49	54.14	31.10	25.57	161.57
TAXES	22.15	14.34	7.48	6.29	41.63
PAT	67.35	39.85	23.80	19.37	119.99
EPS	64.90	38.36	22.76	18.16	115.12
Raw Material	47.87	44.68	50.07	45.10	43.69
Power and Fuel	5.31	6.31	5.61	5.17	2.43
Employee Cost	10.74	11.83	10.60	11.93	4.42
Other Manufacturing Expenses	0.42	0.70	1.53	2.05	1.01
Selling and Administration Expenses	8.25	9.40	9.38	12.29	10.39
Miscellaneous Expenses	0.24	0.56	0.76	0.70	0.14
Revenue (Growth %)	35.90	20.52	22.36	-44.97	74.11
PBIDT (Growth %)	46.13	34.83	31.13	-73.43	475.55
PAT (Growth %)	69.02	67.44	22.84	-83.86	692.24
PBIDT (Margin %)	23.91	22.23	19.87	18.54	38.40
PAT (Margin %)	13.39	10.76	7.75	7.72	26.30

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Share Capital	10.38	10.38	10.38	10.38	10.38	10.38
Reserves Total	323.00	255.47	215.57	191.65	172.18	52.13
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	333.38	265.85	225.95	202.03	182.56	62.51
Secured Loans	130.46	112.45	98.12	90.15	53.31	32.72
Unsecured Loans	0.00	0.00	0.00	0.12	0.70	8.51
Total Debt	130.46	112.45	98.12	90.27	54.01	41.23
Other Liabilities	7.37	0.25	0.22	0.90	0.75	9.86
Total Liabilities	471.21	378.55	324.29	293.20	237.32	113.60
APPLICATION OF FUNDS :
Gross Block	259.44	229.75	205.21	168.72	126.70	80.79
Less : Accumulated Depreciation	105.08	85.29	67.03	49.15	35.93	25.27
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	154.36	144.46	138.18	119.57	90.77	55.52
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	17.01	0.00	0.00	14.29	12.15	2.89
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	3.55	3.55	3.55	3.55	3.55	8.72
Current Assets, Loans & Advances
Inventories	78.25	83.47	78.39	93.37	53.36	17.36
Sundry Debtors	281.22	155.90	115.98	73.29	70.71	37.78
Cash and Bank Balance	3.54	14.29	5.04	6.09	10.87	5.13
Loans and Advances	43.78	31.26	43.97	41.83	92.37	41.17
Total Current Assets	406.79	284.91	243.37	214.57	227.32	101.44
Less : Current Liabilities and Provisions
Current Liabilities	115.87	66.08	66.69	56.49	64.08	49.39
Provisions	8.59	6.10	6.60	13.53	41.00	5.80
Total Current Liabilities & Provisions	124.46	72.18	73.29	70.03	105.08	55.19
Net Current Assets	282.33	212.73	170.08	144.54	122.23	46.25
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	2.50	1.61	0.03	0.00	0.04	0.20
Deferred Tax Liability	0.00	0.00	0.00	0.41	0.31	0.16
Net Deferred Tax	2.50	1.61	0.03	-0.41	-0.27	0.04
Other Assets	11.45	16.19	12.44	11.64	8.89	0.17
Total Assets	471.20	378.55	324.28	293.19	237.32	113.59
Contingent Liabilities	36.98	36.98	0.35	0.51	0.05	0.59

Cash Flow (₹ in cr)

Yearly Cash Flow	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Financing Activities	5.66	0.99	-17.40	-14.44	7.04
Investing Activities	-62.98	-48.44	-26.40	-28.13	-34.91
Net Cash Flow	1.93	-5.26	-0.45	10.20	-10.87
Operating Activities	59.24	42.19	43.35	52.77	17.00

Peers

Balance Sheet Financial Ratios Profit & Loss

Aarti Pharmalabs...

1,010.50

(+9.42%)

Accent Microcell...

609.35

(+0.90%)

Accretion Pharma...

213.90

(+4.98%)

Achyut Healthcar...

Advanced Enzyme ...

284.10

(+0.21%)

Akums Drugs & Ph...

749.90

(-2.59%)

Albert David Ltd

789.00

(-3.17%)

Alembic Pharmace...

1,047.25

(+1.68%)

Corporate Actions

Bonus Dividends Splits

Date	Corporate Action	Information
No Corporate Actions Announced

Board of Directors

Functional Directors

Ramesh Kumar

Executive Director & MD

Exec.

Ajay Arora

E D & Wholetime Director

Dir.

Aditya Arora

Executive Director / Whole Time Director / CFO

Exec.

Geeta Arora

E D & Wholetime Director

Dir.

Anju Arora

E D & Wholetime Director

Dir.

Independent Directors

Prashanth Vellanki

Independent Non Exe. Director

Ind.

VKS

Vinod Kumar Sharma

Independent Non Exe. Director

Ind.

Bhavesh Mahajan

Independent Non Exe. Director

Ind.

PSB

PreetMohinder Singh Bedi

Independent Non Exe. Director

Ind.

Swanith Kapoor

Independent Non Exe. Director

Ind.

Other Officials

Gurpreet Kaur

Company Sec. & Compli. Officer

Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Kwality Pharmaceuticals Ltd? −

Kwality Pharmaceuticals Ltd trades on NSE under KPL and on BSE under code 539997. The ISIN is INE552U01010 and the face value is Rs 10.

What is the share price of Kwality Pharmaceuticals Ltd today? +

As of 12 November 2026, Kwality Pharmaceuticals Ltd trades at Rs 3,948.70, a change of -35.10 (-0.88%) on the day. Prices are live and subject to change.

What is the market capitalisation of Kwality Pharmaceuticals Ltd? +

As of 12 November 2026, Kwality Pharmaceuticals Ltd has a market cap of about Rs 4135.49 crore. This figure is live and moves with the share price.

Is Kwality Pharmaceuticals Ltd profitable? +

In March 2026, Kwality Pharmaceuticals Ltd reported a profit after tax of Rs 67.35 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Kwality Pharmaceuticals Ltd? +

: As of 12 November 2026, the PE (TTM) for Kwality Pharmaceuticals Ltd is 50.66 and the price-to-book ratio is 12.43. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Kwality Pharmaceuticals Ltd pay a dividend? +

As of 12 November 2026, the dividend yield for Kwality Pharmaceuticals Ltd is 0%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Kwality Pharmaceuticals Ltd? +

As of the latest disclosed pattern, promoters hold 54.86% of Kwality Pharmaceuticals Ltd. Public shareholding is 45.14%, including mutual funds at 0.00% and foreign institutional investors at 2.50%.

What were the latest annual financials of Kwality Pharmaceuticals Ltd? +

In March 2026, Kwality Pharmaceuticals Ltd reported net sales of Rs 503.08 crore, revenue growth of 35.90%, and earnings per share of Rs 64.90.